EUVIMEDEUVIMED entdecken
Kohortenstudie

Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study

Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 20-20

DOI: 10.1111/ajco.70235 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study. Asia-Pacific Journal of Clinical Oncology, 22(S6), 20-20. https://doi.org/10.1111/ajco.70235

Vancouver

Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):20-20. doi:10.1111/ajco.70235

BibTeX
@article{euvimed2026,
  title = {Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {S6},
  pages = {20--20},
  doi = {10.1111/ajco.70235}
}
Kostenlos starten →